RxDoctor Payments Data

William Beutler, MD

Neurological Surgery · Harrisburg, PANPI 1649274689

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $200,157 of the $202,901 with a category attached, or 98.6%. Globus Medical accounts for 87.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $75,762 and has fallen 99.7% since, to $248 in 2024. Among neurological surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$202,901in general payments, 2019–2025

Across 27 payments — averaging $7514.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$178K
  • Aesculap Implant Systems, LLC$22K
  • CTL Medical Corporation$2K
  • Stryker$622
  • Cerapedics Inc.$338
  • Kuros Biosciences USA, Inc$128
  • plus $157 from 2 others

What the payments were for

  • Royalty or licence$200,15799%
  • Consulting fees$1,5001%
  • Travel & lodging$3170%
  • Food & beverage$9270%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$202,901 in reported general payments places this provider in the 95th percentile of 390 neurological surgery providers in Pennsylvania.

See all neurological surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$86,411
Medicare patients
159
Services billed
431

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam30$62

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Harrisburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →